Alpha Sense BI

AUGUST 30, 2023

AI has become more prevalent in every part of asset management, from opportunity identification to due diligence to invest men t decision-making to perfor man ce analysis to ongoing portfolio management and more.

Management 98

Management Biotech Due Diligence Algorithm 98

Alpha Sense BI

MAY 5, 2023

Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97

Biotech Capital Banking Startups 97

Alpha Sense BI

APRIL 29, 2024

Traditional due diligence for start-up investors has historically been riddled with inefficiencies—tying up resources to sort through countless documents and copious amounts of data, and manually crafting market comparisons and performance. There is no doubt that generative AI has emerged as a powerful tool in the investment space.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

APRIL 19, 2024

Quantum Computing is Generating Investor Buzz Like spatial computing, quantum computing is a relatively new term gaining traction with investors, venture capitalists, as well as biotech and healthcare startups, demonstrating a broad range of potential use cases —including financial modeling, weather forecasting, genome sequencing, drug discovery, cryptography, (..)

Technology 69

Technology Technology Retail Biotech 69

Alpha Sense BI

APRIL 12, 2024

For a healthcare engineer in the biotech engineering space, I’m gonna be really technical and get down to the nitty gritty behind the actual chemistry. You’re actually talking to the technologists, like the person building the code, the person selling the code, so you create different sets of questions depending on who the person is.” ”For

Primary Research 52

Primary Research Advantage Advantage Research 52

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. He holds B.A. degrees in Neuroscience and Behavior, Genetics, and Economics from Columbia University.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

MARCH 13, 2024

According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs. Take your M&A due diligence to the next level with our Complete Guide to M&A Due Diligence.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59